Our 2030 Vision Bladex Investor Day March 2026 Disclaimer This presentation contains forward -looking statements of expected future developments within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934 . Forward -looking statements can be identified by words such as : "anticipate", "intend", "plan", "goal", "seek", "believe", "project", "estimate", "expect", "strategy", "future", "likely", "may", "should", "will" and similar references ...

Zillow Group (NasdaqGS:Z) Update / briefing March 24, 2026 09:00 AM ET Company ParticipantsBrad Berning - VP of Investor RelationsCameron Swiggett - VP of Product ManagementCynthia Taylor - SVP of Agent Software and AdvertisingDae Lee - VP of Equity ResearchDavid Beitel - CTOJeremy Hofmann - CFOJeremy Wacksman - CEOJohn Colantuoni - Managing DirectorLloyd Frink - Co-founder and Co-Executive ChairmanMary Ellen D'Amico - Director of Investor RelationsMatt Cost - Executive DirectorMichael Sherman - SVP of Zill ...

Achieve Life Sciences (NasdaqCM:ACHV) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJaime Xinos - Chief Commercial OfficerMark Oki - CFOMark Rubinstein - CMONicole Jones - VP of Strategic Communications and Stakeholder RelationsRick Stewart - President and CEOConference Call ParticipantsBrandon Folkes - AnalystJason Butler - Managing Director and Biotechnology Equity Research AnalystJohn Vandermosten - Senior AnalystJustin Walsh - AnalystThomas Gladen - AnalystOperatorGreetings, and w ...

LENZ Therapeutics (NasdaqGS:LENZ) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsAlyssa Larios - Research AssociateDan Chevallard - CFOEvert Schimmelpennink - President and CEOMelanie Gloria - Equity Research AssociateShawn Olsson - Chief Commercial OfficerConference Call ParticipantsBrian Abrahams - Senior Research AnalystLachlan Hanbury-Brown - Equity Research AnalystMatthew Caufield - Director and Senior Biotechnology Equity Research AnalystStacy Ku - Biotech AnalystYigal Nochomovit ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJeff Hackman - CEOPierre S. Sayad - Chief Medical OfficerRobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystNone - AnalystNone - AnalystOperatorGood morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter and full year ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsAlex von Riesemann - AVP of Biotech Equity ResearchJeff Hackman - CEOPierre S. Sayad - Chief Medical OfficerRobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystSudan Loganathan - Biotechnology Equity Research AnalystOperatorGood morning, ladies ...

Fennec Pharmaceuticals (NasdaqCM:FENC) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsJeffrey S. Hackman - CEOPierre S. Sayad - CMORobert Andrade - CFOConference Call ParticipantsChase Knickerbocker - Senior Research AnalystMadison El-Saadi - Healthcare Equity Research AnalystRaghuram Selvaraju - Managing Director and Equity Research AnalystSudhanva Nathan - AnalystNone - AnalystOperatorGood morning, ladies and gentlemen. Welcome to Fennec Pharmaceuticals' fourth quarter and full year ...

Core & Main (NYSE:CNM) Q4 2026 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsBrad Cowles - PresidentGlenn Floyd - Director of Investor RelationsJoe Ritchie - Managing DirectorMark Witkowski - CEOMike Dahl - Managing Director, Equity ResearchNigel Coe - Managing DirectorRobyn Bradbury - CFOConference Call ParticipantsDavid Manthey - Senior Research AnalystMatt Johnson - Equity Research AnalystOperatorHello, and welcome to the Core & Main Q4 and full year 2025 earnings call. My name is Alex. I' ...

Lument Finance Trust (NYSE:LFT) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsAndrew Tsang - Managing Director of Corporate DevelopmentChris Muller - Director Equity ResearchGreg Calvert - PresidentJason Weaver - Managing DirectorJim Briggs - CFOJim Flynn - CEOZach Halpern - Portfolio ManagerConference Call ParticipantsLee Zuk - AnalystOperatorGood morning, and thank you for joining the Lument Finance Trust fourth quarter 2025 earnings call. Today's call is being recorded and will be ...

Vertical Aerospace (NYSE:EVTL) Q4 2025 Earnings call March 24, 2026 08:30 AM ET Company ParticipantsDavid King - Chief EngineerDómhnal Slattery - ChairmanEdison Yu - DirectorSamuel Emden - Head of Investor AffairsStuart Simpson - CEONone - Video NarratorConference Call ParticipantsAmit Dayal - Managing Director and Senior Equity AnalystAustin Moeller - Senior Aerospace and Defense Technology AnalystChris Pierce - Senior AnalystDavid Zazula - AnalystLouie DiPalma - AnalystOperatorThank you for standing by. M ...